To effectively address critical questions related to the adoption and deployment of in silico methods for specific topics, the Avicenna Alliance has established dedicated Task Forces, composed of experts from various fields, ensuring a multidisciplinary approach to solving complex issues.
These groups collaborate to achieve concrete progress for matters as diverse as In silico AI, Patient involvement, Horizon Europe Projects, Pharmaceutical strategy, In silico oncology, Notified Bodies and Standard Organizations, etc.
By leveraging diverse expertise and fostering strong industry-academia relationships – each Task Force is led by 2 co-chairs one from academia and one from industry - the Task Forces aim to pave the way for widespread implementation and acceptance of in silico practices, ultimately benefiting patients and advancing scientific progress.
NEWS
News

The Avicenna Alliance Publishes its Fourth Edition of the In Silico Medicine Glossary
The Avicenna Alliance is pleased to announce the release of its Fourth Edition of the Avicenna Alliance Glossary, an essential resource aimed at defining and clarifying key concepts in the field of in silico medicine.
News

Welcome on Board, Hemolens Diagnostics!
We are delighted to welcome Hemolens Diagnostics as a new member of the Avicenna Alliance!
News

Poll on Computer Modelling & Simulation
The Avicenna Clinical Deployment Task Force, led by Co-Chairs Erica Beaucage-Gauvreau & René Bombien, is engaged to grow a network of professionals with expertise in clinical applications of in silico methodologies, to foster collaboration and knowledge exchange.